Patents by Inventor Trevor Warren Lissoos

Trevor Warren Lissoos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210252141
    Abstract: The invention features new a method for treating inflammatory bowel disease, including Crohn's Disease (CD) or ulcerative colitis in a human patient, comprising administering to a patient a combination therapy comprising an anti-?4?7 antibody, a TNF? antagonist, and an immunomodulator.
    Type: Application
    Filed: January 19, 2021
    Publication date: August 19, 2021
    Inventors: Trevor Warren Lissoos, Jean-Frederic Colombel
  • Patent number: 10918716
    Abstract: The invention features new a method for treating inflammatory bowel disease, including Crohn's Disease (CD) or ulcerative colitis in a human patient, comprising administering to a patient a combination therapy comprising an anti-?4?7 antibody, a TNF? antagonist, and an immunomodulator.
    Type: Grant
    Filed: May 4, 2017
    Date of Patent: February 16, 2021
    Assignees: Millennium Pharmaceuticals, Inc., Icahn School of Medicine at Mount Sinai
    Inventors: Trevor Warren Lissoos, Jean-Frederic Colombel
  • Publication number: 20190142938
    Abstract: The invention features new a method for treating inflammatory bowel disease, including Crohn's Disease (CD) or ulcerative colitis in a human patient, comprising administering to a patient a combination therapy comprising an anti-?4?7 antibody, a TNF? antagonist, and an immunomodulator.
    Type: Application
    Filed: May 4, 2017
    Publication date: May 16, 2019
    Inventors: Trevor Warren Lissoos, Jean-Frederic Colombel